FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to the field of biochemistry, in particular to a humanised antibody to a tumour necrosis factor-α or its antigen-binding fragment Fab. Also disclosed are: gene, coding the protein of the antibody or Fab, genetic material, expressing the said antibody or Fab-fragment. Disclosed are: application of the antibody of Fab for obtaining a medication for the prevention or treatment of diseases, associated with the human tumour necrosis factor-α and a pharmaceutical composition for the treatment of diseases, associated with the human tumour necrosis factor-α, containing an effective quantity of the said antibody or Fab.
EFFECT: invention possesses a reduced immune response, in comparison with the pharmaceutical antibody Remicade, which makes it possible to treat diseases, associated with the human tumour necrosis factor-α, in an effective way.
23 cl, 5 dwg, 9 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
VARIABLE DOMAINS OF LIGHT AND HEAVY CHAIN OF MURINE MONOCLONAL ANTIBODY AGAINST TUMOUR NECROSIS FACTOR ALPHA (TNF-α) OF HUMAN BEING (VERSIONS); ANTIGEN-BINDING FRAGMENT (Fab) AGAINST TNF-α OF HUMAN BEING, WHICH CONTAINS ABOVE SAID DOMAINS (VERSIONS) | 2012 |
|
RU2499000C1 |
HUMANISED ANTIBODY AND ANTIGENBINDING FRAGMENT (Fab), WHICH BINDS WITH HUMAN INTERFERON-γ, DNA FRAGMENTS CODING CLAIMED ANTIBODY AND ANTIGEN-BINDING FRAGMENT, CELL, TRANSFORMED BY DNA FRAGMENT, AND METHOD OF OBTAINING CLAIMED ANTIBODY AND ANTIGEN-BINDING FRAGMENT | 2013 |
|
RU2539752C2 |
HUMANISED ANTIBODIES AND Fab BOUND WITH ANTIGEN F1 OF Yersinia pestis, AND METHOD FOR PRODUCING THEREOF WITH USING YEAST | 2009 |
|
RU2420587C2 |
HUMANIZED ANTI-VEGF MONOCLONAL ANTIBODY | 2020 |
|
RU2809746C2 |
RECOMBINANT ANTIBODY IL4 USED FOR TREATMENT OF DISORDERS ASSOCIATED WITH FUNCTION OF IL4 | 1994 |
|
RU2162711C2 |
ANTIGEN BINDING SECTION (FAB), INCLUDING HUMANIZED FAB, AGAINST BOTULINICAL NEUROTOXIN C (VERSIONS), METHOD TO OBTAIN FAB USING YEAST, METHOD AND SET FOR BOTULINICAL NEUROTOXIN C DETECTION | 2016 |
|
RU2623157C1 |
HUMANISED ANTIGEN-BINDING FRAGMENTS (Fab) AGAINST RABIES VIRUS, ISOLATED DNA FRAGMENT, CODING Fab AGAINST RABIES VIRUS, YEAST CELL, TRANSFORMED BY DNA FRAGMENT, AND METHOD OF OBTAINING Fab AGAINST RABIES VIRUS WITH APPLICATION OF YEASTS | 2010 |
|
RU2440412C2 |
Siglec-15 ANTIBODY | 2010 |
|
RU2539790C2 |
NEW ANTI-DR5 ANTIBODY | 2011 |
|
RU2590711C2 |
Fab FRAGMENT OF HUMANIZED ANTIBODY AGAINST VEGF AND ITS USE | 2020 |
|
RU2802960C2 |
Authors
Dates
2015-07-20—Published
2011-09-30—Filed